233 related articles for article (PubMed ID: 9516140)
1. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.
Wang JC; Lapidot T; Cashman JD; Doedens M; Addy L; Sutherland DR; Nayar R; Laraya P; Minden M; Keating A; Eaves AC; Eaves CJ; Dick JE
Blood; 1998 Apr; 91(7):2406-14. PubMed ID: 9516140
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells.
Lewis ID; McDiarmid LA; Samels LM; To LB; Hughes TP
Blood; 1998 Jan; 91(2):630-40. PubMed ID: 9427719
[TBL] [Abstract][Full Text] [Related]
3. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
[TBL] [Abstract][Full Text] [Related]
4. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
Eisterer W; Jiang X; Christ O; Glimm H; Lee KH; Pang E; Lambie K; Shaw G; Holyoake TL; Petzer AL; Auewarakul C; Barnett MJ; Eaves CJ; Eaves AC
Leukemia; 2005 Mar; 19(3):435-41. PubMed ID: 15674418
[TBL] [Abstract][Full Text] [Related]
5. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.
Sirard C; Lapidot T; Vormoor J; Cashman JD; Doedens M; Murdoch B; Jamal N; Messner H; Addey L; Minden M; Laraya P; Keating A; Eaves A; Lansdorp PM; Eaves CJ; Dick JE
Blood; 1996 Feb; 87(4):1539-48. PubMed ID: 8608245
[TBL] [Abstract][Full Text] [Related]
6. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
[TBL] [Abstract][Full Text] [Related]
7. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment.
van Hennik PB; de Koning AE; Ploemacher RE
Blood; 1999 Nov; 94(9):3055-61. PubMed ID: 10556189
[TBL] [Abstract][Full Text] [Related]
8. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.
Dazzi F; Capelli D; Hasserjian R; Cotter F; Corbo M; Poletti A; Chinswangwatanakul W; Goldman JM; Gordon MY
Blood; 1998 Aug; 92(4):1390-6. PubMed ID: 9694728
[TBL] [Abstract][Full Text] [Related]
9. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
Lapidot T; Grunberger T; Vormoor J; Estrov Z; Kollet O; Bunin N; Zaizov R; Williams DE; Freedman MH
Blood; 1996 Oct; 88(7):2655-64. PubMed ID: 8839860
[TBL] [Abstract][Full Text] [Related]
10. Cell separation improves the sensitivity of detecting rare human normal and leukemic hematopoietic cells in vivo in NOD/SCID mice.
Holyoake TL; Horrocks C; Thomas T; Eaves CJ; Eaves AC
Cytotherapy; 2000; 2(6):411-21. PubMed ID: 12044221
[TBL] [Abstract][Full Text] [Related]
11. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.
Piacibello W; Sanavio F; Severino A; Danè A; Gammaitoni L; Fagioli F; Perissinotto E; Cavalloni G; Kollet O; Lapidot T; Aglietta M
Blood; 1999 Jun; 93(11):3736-49. PubMed ID: 10339480
[TBL] [Abstract][Full Text] [Related]
12. Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation.
Dazzi F; Hasserjian R; Gordon MY; Boecklin F; Cotter F; Corbo M; Capelli D; Goldman JM
Hematol J; 2000; 1(5):307-15. PubMed ID: 11920208
[TBL] [Abstract][Full Text] [Related]
13. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
[TBL] [Abstract][Full Text] [Related]
14. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells.
van der Loo JC; Hanenberg H; Cooper RJ; Luo FY; Lazaridis EN; Williams DA
Blood; 1998 Oct; 92(7):2556-70. PubMed ID: 9746798
[TBL] [Abstract][Full Text] [Related]
15. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice.
Cashman JD; Lapidot T; Wang JC; Doedens M; Shultz LD; Lansdorp P; Dick JE; Eaves CJ
Blood; 1997 Jun; 89(12):4307-16. PubMed ID: 9192753
[TBL] [Abstract][Full Text] [Related]
16. Engraftment of chronic myeloid leukemia in SCID mice.
Hoyle CF; Negrin RS
Hematol Oncol; 1998 Sep; 16(3):87-100. PubMed ID: 10235067
[TBL] [Abstract][Full Text] [Related]
17. Differences between normal and CML stem cells: potential targets for clinical exploitation.
Eaves AC; Barnett MJ; Ponchio L; Cashman JD; Petzer AL; Eaves CJ
Stem Cells; 1998; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
[TBL] [Abstract][Full Text] [Related]
18. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
19. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
20. Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice.
Hogan CJ; Shpall EJ; McNulty O; McNiece I; Dick JE; Shultz LD; Keller G
Blood; 1997 Jul; 90(1):85-96. PubMed ID: 9207442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
